Budget Impact Analysis Of The Introduction Of Saxagliptin/Metformin Extended-Release (Xr) In The Treatment Of Type-2 Diabetes In Chile
Abstract
Authors
JF Elgart L Gonzalez EC Aiello JJ Gagliardino
JF Elgart L Gonzalez EC Aiello JJ Gagliardino
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now